Yao, Xueting
Yan, Xiaoyu
Wang, Xiaohan
Cai, Ting
Zhang, Shun
Cui, Cheng
Wang, Xiaoxu
Hou, Zhe
Liu, Qi
Li, Haiyan
Lin, Jing
Xiong, Zi
Liu, Dongyang http://orcid.org/0000-0002-0608-8192
Funding for this research was provided by:
Ministry of Science and Technology (MOST) of the People’s Republic of China foundation for SARS-nCov-2 Research (No. 2020YFC0844500)
Bill & Melinda Gates Foundation (No. INV-015694)
Article History
Received: 28 May 2020
Accepted: 25 October 2020
First Online: 13 November 2020
Compliance with ethical standards
:
: The authors have no conflict of interest to disclose.
: A clinical pharmacokinetic study was approved by the Ethics Committee of Ningbo Hwamei Hospital, University of Chinese Academy of Sciences (Ningbo, China) (ethical review approval number: PJ-NBEY-KY-2020-063-01).
: All enrolled subjects signed the Informed Consent Form (ICF) before the study was conducted.
: All co-authors have reviewed and approved this manuscript for publication.
: The NONMEM code was provided in the supplementary file.